Negatively charged cell surface components and extracellular matrix proteins

Negatively charged cell surface components and extracellular matrix (ECM) proteins encompass a diverse array of polyanionic molecules, most notably glycosaminoglycans (GAGs) such as heparan sulfate, chondroitin sulfate, and hyaluronic acid, as well as sialic acid-rich glycoproteins (Source: NIH, StatPearls). These molecules form the glycocalyx, a dense carbohydrate layer that coats the surface of nearly all eukaryotic cells and provides structural scaffolding within the ECM. Biologically, these components are essential for regulating cell signaling by sequestering growth factors, facilitating cell-matrix adhesion, and maintaining tissue hydration and elasticity (Source: UniProt, Journal of Cell Biology). In clinical contexts, these negatively charged moieties often serve as primary attachment sites for various pathogens, including viruses like herpes simplex and SARS-CoV-2, as well as certain bacteria (Source: Nature Reviews Microbiology). Therapeutic strategies targeting these components often utilize cationic molecules, such as polymyxins or antimicrobial peptides, which bind via electrostatic interactions to disrupt microbial membranes or block viral entry (Source: PubChem, PubMed). However, the ubiquitous nature of these polyanions across different tissue types poses significant challenges for drug specificity and can lead to systemic safety concerns like nephrotoxicity (Source: Clinical Microbiology Reviews).

Other names

Cell surface polyanionsExtracellular matrix polyanionsGlycocalyx componentsAnionic cell surface sitesSurface glycosaminoglycans

Drugs typically interact with these components through electrostatic attraction between cationic drug moieties and the anionic sulfate or carboxylate groups on the target, thereby neutralizing surface charge, disrupting microbial membranes, or competitively inhibiting ligand/pathogen binding.